Clinical trials
Fetal Growth Retardation trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Recruiting | 6 |
| Unknown status | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 6 |
| Central Hospital, Nancy, France | 3 |
| Pfizer | 2 |
| University Hospital, Bordeaux | 2 |
| University Hospital, Grenoble | 2 |
| University Hospital, Rouen | 2 |
| Centre Hospitalier Intercommunal Creteil | 1 |
| Centre Hospitalier Metropole Savoie | 1 |
| Centre Hospitalier Universitaire de Nīmes | 1 |
| Centre Hospitalier Universitaire de Saint Etienne | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fetal Growth Retardation | 28 |
| Pre-Eclampsia | 8 |
| Abruptio Placentae | 3 |
| HELLP Syndrome | 2 |
| Hypertension | 2 |
| Perinatal Death | 2 |
| Premature Birth | 2 |
| Stillbirth | 2 |
| Abortion, Spontaneous | 1 |
| Diabetes, Gestational | 1 |
Trials
Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.